Company: BNBX
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001410578-25-001814
Chunk: 1

Company: BNB PLUS CORP.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1F
Chunk 1
---
Item 1 - Financial Statements

APPLIED DNA SCIENCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

​

​​​​​​​​    June 30,     September 30, ​​2025​2024ASSETS​(unaudited)​​​Current assets: ​   ​  Cash and cash equivalents​$ 4,727,677​$ 5,852,363Accounts receivable, net of allowance for credit losses of $80,423 and $75,000 at June 30, 2025 and September 30, 2024, respectively​  199,047​  328,252Inventories​  338,723​  432,725Prepaid expenses and other current assets​  338,447​  756,185Current assets of discontinued operations​​ 25,008​​ 678,146Total current assets​  5,628,902​  8,047,671​​​​​​​Property and equipment, net​  511,203​  458,895Noncurrent assets of discontinued operations​​ 11,264​​ 94,337Other assets:​ ​​  ​Restricted cash​​ 750,000​​ 750,000Intangible assets ​​ 2,698,975​​ 2,698,975Operating right of use asset​​ 334,402​​ 739,162Total assets​$ 9,934,746​$ 12,789,040​​​​​​​LIABILITIES AND EQUITY​   ​   ​​​​​​​Current liabilities:​ ​​   Accounts payable and accrued liabilities ​$ 1,564,707​$ 1,737,366Operating lease liability, current​​ 334,403​​ 545,912Deferred revenue​  12,285​  58,785Current liabilities of discontinued operations​​ 124,565​​ 56,061Total current liabilities​  2,035,960​  2,398,124​​​ ​​​​Long term accrued liabilities​  31,467​  31,467Deferred revenue, long term​​ 194,000​​ 194,000Operating lease liability, long term​​ —​​ 193,249Deferred tax liability, net​​ 684,115​​ 684,115Warrants classified as a liability​​ 1,160​​